Does the benefit from treating to lower blood pressure targets vary with age? A systematic review and meta-analysis

Conclusion: In these novel results, for both RR and absolute risk, treating to SBPs of 120–140 mmHg versus higher targets benefited older patients more than younger patients without an age-related increase in the RR for adverse effects. Nonetheless, because all clinical trials excluded the most frail older patients, clinicians must consider individual patient characteristics such as frailty, autonomy, and cognitive ability when choosing blood pressure targets.
Source: Journal of Hypertension - Category: Cardiology Tags: REVIEWS AND META-ANALYSES Source Type: research